Additional file 5: Figure S2. of miR-539 inhibits prostate cancer progression by directly targeting SPAG5

Abstract

miR-539 is downexpressed in primary PCa and metastatic PCa. miR-539 level was gradually decreased in normal prostate, primary PCa, and metastatic PCa samples. (JPG 173 kb